Skip to content

COMPARISON OF BETA BLOCKERS OR CALCIUM CHANNEL BLOCKERS IN PATIENT WITH SEPSIS.

TO OBSERVE THE INFLUENCE OF PRE ADMISSION BETA BLOCKERS OR CALCIUM CHANNEL BLOCKERS ON COURSE OF THE DISEASE i.e MORBIDITY AND MORTALITY IN PATIENTS WITH SEPSIS. - BIOSEPSIS

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2019/08/021007
Enrollment
114
Registered
2019-08-30
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B998- Other infectious disease

Interventions

None listed

Sponsors

DR RAM MANOHAR LOHIA INSTITUTE OF MEDICAL SCIENCES
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.All patients with diagnosis of sepsis. 2. Patients who will stay in ICU for minimum of 72 hours. 3. Patients who were taking calcium channel blockers or beta blockers prior to admission

Exclusion criteria

Exclusion criteria: 1.Patients or Relatives refusal to give consent. 2.Hemo-dynamically unstable patients. 3.Patients requiring inotropic support(noradrenaline) for hypotension in a dose of more than or equal to 0.1 mcg/kg/min during ICU stay. 4. Age 65 yrs. 5. Patient with septic shock. 6. Previously diagnosed case of sepsis referred from some other centre

Design outcomes

Primary

MeasureTime frame
To observe the influence of pre admission beta blocker or calcium channel blocker on course of disease i.e morbidity and mortality in patients with sepsis.Timepoint: SOFA SCORE assessment along with sepsis markers on day 1, 3 and 7

Secondary

MeasureTime frame
To asses the influence of pre admission beta blocker or calcium channel blocker therapy by SOFA SCORING during ICU stay.Timepoint: SOFA SCORE assessment along with sepsis markers on day 1, 3 and 7

Countries

India

Contacts

Public ContactDR SACHIN KUMAR

DR RAM MANOHAR LOHIA INSTITUTE OF MEDICAL SCIENCES

drdm58@gmail.com05226692063

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026